Arcus Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 05/08/2026 | 31.42 M | $678.77 M | 0.00% | 29.26% |
| BLACKROCK, INC. | 05/13/2026 | 15.23 M | $328.89 M | 1.52% | 14.18% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 6.09 M | $131.53 M | 17.46% | 5.67% |
| STATE STREET CORP | 05/15/2026 | 5.41 M | $116.92 M | 18.26% | 5.04% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 5.03 M | $108.67 M | -3.04% | 4.68% |
| 05/08/2026 | 4.27 M | $92.28 M | 100.00% | 3.98% | |
| 05/15/2026 | 3.86 M | $83.31 M | 100.00% | 3.59% | |
| WOODLINE PARTNERS LP | 05/15/2026 | 3.78 M | $81.60 M | 0.21% | 3.52% |
| MARSHALL WACE, LLP | 05/15/2026 | 3.76 M | $81.25 M | 11.03% | 3.50% |
| SIREN, L.L.C. | 05/14/2026 | 3.01 M | $64.95 M | 0.00% | 2.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.25 M | $48.66 M | 18.09% | 2.10% |
| FISHER ASSET MANAGEMENT, LLC | 05/05/2026 | 2.19 M | $47.31 M | 12.34% | 2.04% |
| SAMLYN CAPITAL, LLC | 05/15/2026 | 1.91 M | $41.22 M | 18.96% | 1.78% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2026 | 1.65 M | $35.74 M | -1.93% | 1.54% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 1.43 M | $30.80 M | -6.43% | 1.33% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.33 M | $28.73 M | 1,170.22% | 1.24% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 1.21 M | $26.08 M | 24.64% | 1.12% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 1.20 M | $25.92 M | 100.00% | 1.12% |
| FMR LLC | 05/15/2026 | 1.17 M | $25.17 M | 2.65% | 1.09% |
| MORGAN STANLEY | 05/15/2026 | 1.11 M | $24.05 M | -8.03% | 1.04% |
| 05/15/2026 | 1.05 M | $22.64 M | 14.36% | 0.98% | |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 999.79 K | $21.60 M | -14.43% | 0.93% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2026 | 923.09 K | $19.94 M | -15.83% | 0.86% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 903.64 K | $19.52 M | -6.67% | 0.84% |
| NORTHERN TRUST CORP | 05/14/2026 | 840.31 K | $18.15 M | 5.73% | 0.78% |
| INVESCO LTD. | 05/12/2026 | 820.82 K | $17.73 M | 98.09% | 0.76% |
| CANDRIAM S.C.A. | 04/30/2026 | 790.61 K | $17.08 M | 0.00% | 0.74% |
| ABRDN PLC | 04/29/2026 | 769.79 K | $16.63 M | 100.15% | 0.72% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 646.07 K | $13.96 M | -35.45% | 0.60% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 582.92 K | $12.59 M | 100.00% | 0.54% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 511.17 K | $11.04 M | 1.33% | 0.48% |
| DECHENG CAPITAL LLC | 05/13/2026 | 477.82 K | $10.32 M | -11.77% | 0.44% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 451.98 K | $9.76 M | -36.52% | 0.42% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2026 | 443.83 K | $9.59 M | 2.90% | 0.41% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2026 | 430.35 K | $9.30 M | -53.73% | 0.40% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 424.70 K | $9.17 M | 1,198.78% | 0.40% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 415.62 K | $8.98 M | 53.93% | 0.39% |
| PRINCIPAL FINANCIAL GROUP INC | 05/04/2026 | 413.78 K | $8.94 M | 1.54% | 0.39% |
| PDT PARTNERS, LLC | 05/15/2026 | 388.34 K | $8.39 M | 0.00% | 0.36% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 381.86 K | $8.25 M | -9.95% | 0.36% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 05/15/2026 | 379.10 K | $8.19 M | 0.00% | 0.35% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 356.54 K | $7.70 M | 48.56% | 0.33% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 312.69 K | $6.75 M | 123.94% | 0.29% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 05/13/2026 | 303.32 K | $6.55 M | 2.67% | 0.28% |
| UBS GROUP AG | 05/05/2026 | 288.86 K | $6.24 M | -29.76% | 0.27% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 281.68 K | $6.08 M | 38.58% | 0.26% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 259.40 K | $5.60 M | 203.14% | 0.24% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 252.93 K | $5.46 M | 100.00% | 0.24% |
| RHUMBLINE ADVISERS | 05/12/2026 | 241.49 K | $5.22 M | 6.32% | 0.22% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 05/15/2026 | 239.97 K | $5.18 M | 0.00% | 0.22% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arcus Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 273 institutional investors and hedge funds held shares of Arcus Biosciences Inc. The most heavily invested institutionals were:
GILEAD SCIENCES, INC.: 31.42 M
BlackRock, Inc.: 15.23 M
WELLINGTON MANAGEMENT GROUP LLP: 6.09 M
STATE STREET CORP: 5.41 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 5.03 M
Woodline Partners LP: 3.78 M
110.87% of Arcus Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 134.35 M shares in the last 24 months. This purchase volume represents approximately $3.15 B in transactions.